Suicide-related events in young people following prescription of SSRIs and other antidepressants: A self-controlled case series analysis

BMJ Open

Volumn 3, Issue 9, 2013, Pages

  Wijlaars, Linda P M M ^a   Nazareth, Irwin ^a   Whitaker, Heather J ^b   Evans, Stephen J W ^c   Petersen, Irene ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; AUTOMUTILATION; CHILD; DEPRESSION; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SCHOOL CHILD; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

EID: 84885366121     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003247     Document Type: Article

References (40)

1. Kessler RC, Avenevoli S, Ries, et al. Mood disorders in children and adolescents: an epidemiologic perspective. Bioll Psychiatry 2001;49:1002-14.
2. Heron M. Deaths: leading causes for 2007. Natl Vital Stat Rep 2011;59:1-95.
3. Hazell P, O'Connell D, Heathcote D, et al Tricyclic drug for depression in children and adolescents. Cochrane Database Syst Rev 2010;(4):CD002317.
4. Wijlaars LP, Nazareth I, Petersen I. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in the health improvement network (THIN). PLoS ONE 2012;7: e33181.
5. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005;330:385.
6. National Institute for Health and Clinical Excellence. CG28 depression in children and young people: NICE guideline. London: National Institute for Health and Clinical Excellence, 2005.
7. FDA. Suicidality in children and adolescents being treated with antidepressant medications. US Food and Drug Administration. 2004. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm161679. htm (accessed 29 June 2011).
8. Whittington CJ, Kendall T, Fonagy P., et al Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5. (Pubitemid 38529872)
9. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-9. (Pubitemid 43345358)
10. Rothman KJ, Michels KB The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8. (Pubitemid 24233862)
11. Grosso A, Douglas I, MacAllister R., et al Use of the self-controlled case series method in drug safety assessment. Expert Opin Drug Saf 2011;10:337-40.
12. Gibbons RD, Brown CH, Hur K, et al Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356-63. (Pubitemid 47461135)
13. Schneeweiss S, Patrick AR, Solomon D.H., et al Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics 2010;125:876-88.
14. Jick H, Kaye JA, Jick SS Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-43. (Pubitemid 38944257)
15. Olfson M, Marcus SC, Shaffer D. Anti-depressant drug therapy and suicide in severely depressed children and adults-a case-control study. Arch Gen Psychiatry 2006;63:865-72. (Pubitemid 44188479)
16. Gibbons RD, Brown CH, Hur K, et al Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomised placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012;69:580-7.
17. Didham RC, McConnell DW, Blair H.J., et al Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication. Br J Clin Pharmacol 2005;60:519-25. (Pubitemid 41532452)
18. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004;12:171-7. (Pubitemid 39534583)
19. Booth N. What are the read codes? Health Libr Rev 1994;11:177-82.
20. Khan NF, Harrison SE, Rose PW Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract 2010;60:e128-36.
21. Arana A, Wentworth CE, yuso-Mateos JL, et al Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010;363:542-51.
22. Davé S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009;18:704-7.
23. British National Formulary. 60th edn. London: BMJ Group, RPS Publishing, 2010.
24. The NHS Information Centre PaPCS. Prescription compliance: a review of the proportion of prescriptions dispensed. 7-9-2011.
25. Whitaker HJ, Farrington CP, Spiessens B, et al Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006;25:1768-97.
26. Whitaker HJ, Hocine MN, Farrington CP The methodology of self-controlled case series studies. Stat Methods Med Res 2009;18:7-26.
27. Taylor MJ, Freemantle N, Geddes J.R., et al Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006;63:1217-23. (Pubitemid 44708080)
28. Farrington CP, Whitaker HJ, Hocine MN Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009;10:3-16. (Pubitemid 352847902)
29. Windfuhr K, While D, Hunt I., et al Suicide in juveniles and adolescents in the United Kingdom. J Child Psychol Psychiatry 2008;49:1155-65.
30. Bridge JA, Goldstein TR, Brent DA Adolescent suicide and suicidal behavior. J Child Psychol Psychiatry 2006;47:372-94. (Pubitemid 43356064)
31. Sinclair LI, Christmas DM, Hood S.D., et al Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry 2009;194:483-90.
32. Culpepper L, Davidson JR, Dietrich A.J., et al Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry 2004;65:742-9.
33. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 2009;180:291-7.
34. Hetrick SE, McKenzie JE, Cox G.R., et al Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2012;11:CD004851.
35. Wheeler BW, Gunnell D, Metcalfe C., et al The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. BMJ 2008;336:542-5. (Pubitemid 351413279)
36. Simon GE, Savarino J, Operskalski B., et al Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163:41-7.
37. Bridge JA, Iyengar S, Salary C.B., et al Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297:1683-96.
38. Barbui C, Hotopf M, Freemantle N., et al Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev 2000; (4):CD002791.
39. Fitzpatrick C, Abayomi NN, Kehoe A, et al Do we miss depressive disorders and suicidal behaviours in clinical practice? Clin Child Psychol Psychiatry 2012;17:449-58.
40. van Staa T., Goldacre B, Gulliford M., et al Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ 2012;344:e55.